Unit Code 88830:
C5-OH Acylcarnitine, Quantitative, Urine
Useful For
Evaluation of patients with an abnormal newborn screen showing
elevations of C5-OH
Clinical Information
The differential diagnosis of an isolated elevation of 3-hydroxy
isovalerylcarnitine (C5-OH) in newborn screening blood spots
includes 3-methylcrotonyl-CoA carboxylase deficiency (common
name: 3-methylcrotonylglycinuria), either infantile or maternal;
3-hydroxy 3-methylglutaryl-(HMG)-CoA lyase deficiency;
beta-ketothiolase deficiency; 2-methyl 3-hydroxy butyryl-CoA
dehydrogenase deficiency; 3-methylglutaconic aciduria type I;
and, in some cases, biotinidase deficiency and holocarboxylase
deficiency. Follow-up confirmatory and diagnostic testing is
necessary to differentiate the different clinical entities. Preliminary
data show that this test can be of some utility in the differential
diagnosis of infants who have a positive newborn screening
result for C5-OH.
Reference Values
<2.93 millimoles/mole creatinine
Interpretation
Preliminary data showed that an elevated excretion in urine and
concentration in plasma of C5-OH can be the only biochemical
abnormalities in patients with 3-methylcrotonylglycinuria.
Cautions
The results of urine acylcarnitines are not informative when
the patient is receiving L-carnitine supplements.
Clinical Reference
Wolfe LA, Finegold DN, Vockley J, et al: Potential misdiagnosis of
3-methylcrotonyl-coenzyme A carboxylase deficiency associated
with absent or trace urinary 3-methylcrotonylglycine. Pediatrics
2007; in press


